MicroPort CardioFlow Medtech Corporation (HKG:2160)

Market Cap	4.05B +34.3%
Revenue (ttm)	402.73M -4.0%
Net Income	5.32M
EPS	0.01
Shares Out	1.27B
PE Ratio	278.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,532,200
Average Volume	739,516
Open	3.080
Previous Close	3.090
Day's Range	3.080 - 3.220
52-Week Range	2.940 - 8.450
Beta	0.29
RSI	37.32
Earnings Date	Mar 30, 2026

About HKG:2160

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, tran...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 417
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2160

Financial Performance

In 2024, HKG:2160's revenue was 361.57 million, an increase of 7.54% compared to the previous year's 336.22 million. Losses were -49.45 million, -89.51% less than in 2023.

Financial numbers in CNY